Oxafrit Injection contains Oxacillin 1gm, a penicillinase-resistant penicillin antibiotic indicated for the treatment of serious bacterial infections caused by susceptible Staphylococcus species. It helps in managing infections of the skin, soft tissues, respiratory tract, bones, joints, and bloodstream.
Oxacillin works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death. Its resistance to penicillinase makes it especially effective against penicillin-resistant staphylococcal infections in hospital and critical care settings.
For distributors and healthcare suppliers, Oxafrit Injection is a high-demand injectable antibiotic, widely used in hospitals, nursing homes, and surgical units. The rising incidence of resistant bacterial infections ensures consistent and long-term market demand.
Adding Oxafrit Injection to your injectable antibacterial therapy segment creates strong opportunities in hospital supply chains, critical care units, export markets, and third-party manufacturing. Its proven clinical efficacy, trusted antibiotic class, and broad hospital usage make it a valuable addition to pharmaceutical distribution portfolios.